The treatment for chronic myeloid leukemia (CML) has come a long way with such novel drugs as imatinib, a tyrosine kinase inhibitor, but the mechanism of action is incapable of completely eliminating ...

NICE, the healthcare guidance body, has today published final guidance recommending a new treatment for chronic myeloid leukaemia (CML). Final guidance recommends nilotinib (Tasigna, Novartis) for the ...

Researchers aim to eliminate leukemia stem cells safely. Although tyrosine kinase inhibitors (TKIs) produce remarkable results in patients with chronic myeloid leukemia (CML) by suppressing BCR-ABL1 ...

The labeling for Sprycel (dasatinib; Bristol-Myers Squibb and Otsuka) has been updated with new three-year efficacy and safety data in patients with newly diagnosed Philadelphia chromosome-positive ...

CML Monitor Provides Innovative Method for Tracking Symptoms and Monitoring BCR-ABL Lab Test Results for Physicians and People Living with CML This new app simplifies daily life for people living with ...

Researchers investigate the expression of PARP1 in leukemias with BCR::ABL1 p190+ translocation, finding differential expression in ALL, AML, and CML but no significant correlation with clinical ...

Chronic myeloid leukemia (CML) is highly treatable. With an experienced care team, most people do well for many years on medicines they take at home. At Fred Hutch Cancer Center, our CML experts ...